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Abstract
Among the 1233 Salmonella enterica isolates obtained in two
Spanish hospitals, ﬁve isolates (0.4%) (serovars: Virchow, four;
Livingstone, one) had the phenotype of an extended-spectrum
b-lactamase (ESBL) producer. The genetic characterization of
the ESBL of S. enterica Livingstone revealed a blaSHV-2 gene. The
blaCTX-M-10 gene in a phage-related genetic environment was
found in one S. enterica Virchow isolate, and the blaCTX-M-9 gene
within the In60 integron was found in the three remaining
Virchow isolates. These three isolates presented indistinguish-
able or closely related pulsed-ﬁeld gel electrophoresis patterns
among themselves and also as compared with the two other
blaCTX-M-9-containing isolates previously obtained from animals.
ESBL production is an emerging mechanism of resistance in
S. enterica in the two studied hospitals.
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Salmonella enterica is a zoonotic bacterium, transmitted
through the food chain, which causes gastroenteritis and
other types of infection that require, in some cases, the use
of antimicrobial agents. S. enterica isolates harbouring
extended-spectrum-b-lactamases (ESBLs) have emerged
worldwide during the last years, and ESBLs of the CTX-M
type are increasingly reported in Salmonella, as well as in
other members of the Enterobacteriaceae [1,2]. The occur-
rence of different genes encoding CTX-M enzymes within
sul1-type integron structures that facilitate their dissemina-
tion has been previously reported [3,4], although other
genetic environments have also been described for blaCTX-M
genes [5,6]. The objective of this study was to detect and
characterize the ESBLs in S. enterica isolates recovered in
two Spanish hospitals, and also to determine the genetic
environment of ESBL genes and its possible location within
integron structures.
During the period 2000–2004, a total of 1038 clinical
isolates of S. enterica were recovered from unrelated
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patients in the Complejo Hospitalario of Pontevedra
(a 624-bed institution located in Pontevedra, Galicia, in the
northwest of Spain) (2000–2002, 471 isolates; 2003, 310
isolates; and 2004, 257 isolates). For four of these isolates,
all belonging to serovar Virchow, the MIC of cefotaxime
and/or ceftazidime was ‡2 mg/L and the ESBL screening
test was positive; they were included in this study for
b-lactamase characterization. These isolates were obtained
from ambulatory patients with acute gastroenteritis: one
during the period 2000–2002, one in 2003, and two
in 2004, representing 0.2%, 0.3% and 0.8%, respectively,
of the total isolates in each of the studied periods in this
hospital.
In addition, 195 isolates of S. enterica were recovered dur-
ing 2003 in the Hospital Central of Asturias (a 1357-bed
institution of Oviedo, Asturias, in the north of Spain). For
one isolate (0.5%) (serovar Livingstone), which was recov-
ered from a hospitalized patient with acute gastroenteritis,
the MIC of cefotaxime and/or ceftazidime was ‡2 mg/L and
the ESBL screening test was positive; it was also included in
this study for b-lactamase characterization.
Antimicrobial susceptibility to amoxycillin, amoxycillin–
clavulanic acid, cefotaxime, ceftazidime, cefepime, aztreonam,
imipenem, nalidixic acid, ciproﬂoxacin, gentamicin, amikacin,
tobramycin, streptomycin, fosfomycin, tetracycline, chloram-
phenicol, sulphonamide and trimethoprim–sulphamethoxaz-
ole was determined using disk diffusion and broth
microdilution methods [7]. Escherichia coli ATCC 25922 was
used as a quality control strain. The double-disk synergy test
using amoxycillin–clavulanic acid and cefotaxime or
ceftazidime disks was performed with all isolates to detect
ESBL production [8].
The presence of genes encoding TEM-, SHV-, OXA-,
CTX-M- and CMY-type b-lactamases was studied using spe-
ciﬁc PCRs [9]. All obtained amplicons were sequenced on
both strands, and the sequences were compared with those
included in the GenBank database and at the website http://
www.lahey.org/Studies/, in order to ascribe the speciﬁc type
of b-lactamase gene. The presence of the sul1, sul2 and sul3
genes, associated with sulphonamide resistance, and the
tet(A) and tet(B) genes, associated with tetracycline resis-
tance, were also determined by PCR in the ﬁve isolates [10].
Positive and negative controls from the University of La Rioja
collection were used in all PCRs.
The presence of class 1 integrons as well as the character-
ization of the gene cassettes included in their variable
regions was studied by PCR and sequencing [10]. The PCR
‘primer-walking’ strategy, with a wide variety of primers
based on known sequences [6, 9], was used to amplify over-
lapping fragments, in order to determine the genetic environ-
ment of the blaCTX-M genes.
The ﬁve clinical S. enterica isolates included in this study
represented 0.4% of the total S. enterica isolates obtained in
both hospitals during the studied period. Table 1 shows the
characteristics of the ﬁve ESBL-positive isolates. The genes
encoding both CTX-M-9 and TEM-1b b-lactamases were
detected in three S. enterica serovar Virchow isolates, those
encoding CTX-M-10 and TEM-1b in another serovar
Virchow isolate, and that encoding SHV-2 in the serovar
Livingstone isolate.
The CTX-M-10 b-lactamase was initially described in an
E. coli strain isolated in 1997 in a hospital of Madrid, Spain
[6], and it was later reported in different species of Enterob-
acter and Klebsiella [1,11,12]. This enzyme was found in an
E. coli isolate recovered in 2000 in the north of Spain, and
recently also in an S. enterica serovar Virchow isolate from
the same region [13,14]; no transconjugants of the described
S. enterica strain were obtained after conjugation experi-
ments, and the same result was found (data not shown) with
the S. enterica isolate C683 (Table 1).
The genetic environment of the blaCTX-M-10 gene in the
S. enterica isolate C683, obtained by the PCR primer-walking
TABLE 1. Phenotypes, resistance genes and integron elements detected in the ﬁve extended-spectrum b-lactamase-producing
Salmonella enterica isolates
S. enterica name/
serovar
MIC (mg/L)
Resistance
phenotype
(excluding b-lactams)
Antibiotic resistance genes detected Class integron
AMX AMC CTX CAZ IPM FEP ATM bla Othersa intI1
Gene cassettes
inside VR
C516/Virchow >16 8/4 >128 1 <0.5 >32 4 STR–TET–SUL–SXT–NAL CTX-M-9, TEM-1b tet(A), sul1, sul2 – dfrA16, aadA2
C650/Virchow >16 16/8 >128 1 <0.5 8 2 STR–SUL–SXT–NAL CTX-M-9, TEM-1b sul1, sul2 – dfrA16, aadA2
C651/Virchow >16 8/4 >128 2 <0.5 8 8 STR–TET–SUL–SXT–NAL CTX-M-9, TEM-1b tet(A), sul1, sul2 – dfrA16, aadA2
C683/Virchow >16 <4/2 128 1 <0.5 4 4 SUL–NAL CTX-M-10, TEM-1b – – –
C493/Livingstone >16 <4/2 64 8 <0.5 8 ND STR–TET–SUL SHV-2 tet(A), sul1 – aadA1
AMX, amoxycillin; AMC, co-amoxiclav; CTX, cefotaxime; CAZ, ceftazidime; IPM, imipenem; FEP, cefepime; ATM, aztreonam; STR, streptomycin; TET, tetracycline; SUL, sul-
phonamide; SXT, trimethoprim–sulphamethoxazole; NAL, nalidixic acid; VR, variable region; ND, not determined.
aAntimicrobial resistance genes detected outside of the variable regions of class 1 integrons.
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strategy [6], is shown in Fig. 1. This structure is similar to
that previously reported by Oliver et al. [6] in a blaCTX-M-10-
containing E. coli strain (GenBank accession number
AY598759). This result reveals a linkage of this bla gene to a
phage-related element, in contrast to the truncated ISEcp1
element upstream from the blaCTX-M-10 gene that has been
previously detected in the ﬁrst blaCTX-M-10-containing E. coli
isolate in France [5]. This work provides another example of
the inﬂuence of the genomic environment on local dissemi-
nation of resistance genes, even among different bacterial
genera [6].
The CTX-M-9 group (mainly CTX-M-9 and CTX-M-14
enzymes) is highly represented in Spain and, in the case of
CTX-M-9, is usually linked to class 1 integrons associated
with an ISCR1 element [2,4,15]. For that reason, a wide
variety of primers based on the In60 integron structure
(GenBank accession number AF174129) were used [9,10]
(Fig. 1) in order to explore the genetic environment of the
blaCTX-M-9 gene in the three S. enterica serovar Virchow iso-
lates. Curiously, the intI1 gene was not found by PCR in
any of these three CTX-M-9-producing isolates, even using
other reported primers (data not shown). The genetic envi-
ronment found in the present three clinical blaCTX-M-9-con-
taining isolates was identical to the surrounding region
previously found in S. enterica serovar Virchow isolates of
animal origin [9].
The clonal relationship among the blaCTX-M-9-containing
isolates was studied by pulsed-ﬁeld gel electrophoresis,
following the PulseNet Europe One-day protocol with XbaI
as the restriction enzyme (http://www.pulsenet-europe.org/
docs.htm), and the obtained patterns were found to be indis-
tinguishable from those found in two blaCTX-M-9-containing
S. enterica serovar Virchow isolates previously obtained from
animal samples [9].
All ﬁve isolates of human or animal origin showed indistin-
guishable or closely related patterns, indicating the clonal
relationship among them. This observation is of interest and
suggests a relationship among animal and human blaCTX-M-9-
containing S. enterica isolates that are emerging in both popu-
lations [16]. In addition, it is important to underline that the
observed close clonal relationship of blaCTX-M-9-containing
Salmonella isolates is at variance with the high diversity
among blaCTX-M-9-containing E. coli isolates previously
reported [17–19].
All three blaCTX-M-9-containing isolates showed resistance
to streptomycin, sulphonamide, trimethoprim–sulphamethox-
azole and nalidixic acid, and two of them were also resistant
to tetracycline. In addition to the resistance genes included
in the In60 integron, these isolates also harboured the sul2
gene, in addition to the tet(A) gene in the two tetracycline-
resistant isolates.
The blaSHV-2-containing S. enterica serovar Livingstone iso-
late harboured a class 1 integron that included the aadA1
gene cassette, but the ESBL gene was not found to be associ-
ated with this class 1 integron.
S. enterica isolates producing ESBLs, mainly of the CTX-M
group, seem to be an emerging problem in human medicine.
The detection of closely related or indistinguishable pulsed-
ﬁeld gel electrophoresis patterns among CTX-M-9-producing
S. enterica isolates of both human and animal origin could
indicate the transfer of ESBL-producing S. enterica among
animals and humans. The detection of the blaCTX-M-10 gene
in S. enterica isolates is interesting; this is the second time
that it has been reported in the literature, and its genetic
environment was linked to a phage-related element previ-
ously detected among Enterobacteriaceae. More studies
should be performed in the future to track the evolution of
ESBLs in S. enterica isolates from different environments.
DNA
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FIG. 1. Genetic structures detected surrounding: (a) the blaCTX-M-10 gene in Salmonella enterica serovar Virchow isolate C683; and (b) the
blaCTX-M-9 gene in the three remaining S. enterica serovar Virchow isolates (C516, C650 and C651). The discontinued arrow indicates that the
intI1 gene was not detected; open box, the region that shows high similarity to orf3 of Kluyvera ascorbata; d, 59-be; diagonally striped box,
the recombination site attI; c, indicates the speciﬁc positions of the primers used for PCR primer-walking strategy.
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